Top Japanese Growth Stocks With High Insider Ownership

In This Article:

Japan's stock markets have recently experienced sharp weekly losses, with the Nikkei 225 Index falling by 6.0% and the broader TOPIX Index down by 5.6%. Amid this market volatility, identifying growth companies with high insider ownership can offer unique opportunities for investors seeking stability and potential upside. In this article, we will explore three top Japanese growth stocks characterized by significant insider ownership, a factor that often indicates strong confidence from those closest to the company's operations.

Top 10 Growth Companies With High Insider Ownership In Japan

Name

Insider Ownership

Earnings Growth

Hottolink (TSE:3680)

27%

59.7%

Micronics Japan (TSE:6871)

15.3%

39.8%

Kasumigaseki CapitalLtd (TSE:3498)

34.8%

43.3%

Medley (TSE:4480)

34%

28.7%

Kanamic NetworkLTD (TSE:3939)

25%

28.9%

SHIFT (TSE:3697)

35.4%

32.8%

Money Forward (TSE:3994)

21.4%

66.8%

ExaWizards (TSE:4259)

21.9%

91.1%

Astroscale Holdings (TSE:186A)

20.9%

90%

Soracom (TSE:147A)

16.5%

54.1%

Click here to see the full list of 100 stocks from our Fast Growing Japanese Companies With High Insider Ownership screener.

Below we spotlight a couple of our favorites from our exclusive screener.

DIP

Simply Wall St Growth Rating: ★★★★☆☆

Overview: DIP Corporation, a labor force solution company, provides personnel recruiting services in Japan and has a market cap of ¥163.09 billion.

Operations: The company's revenue segments include personnel recruiting services in Japan.

Insider Ownership: 39.1%

Return On Equity Forecast: 24% (2027 estimate)

DIP Corporation has shown substantial growth with earnings increasing by 20% over the past year and is forecasted to continue growing its revenue at 11.4% annually, outpacing the Japanese market's average. The company recently announced a share repurchase program worth ¥5 billion to enhance shareholder value, indicating strong confidence from insiders. Additionally, DIP's return on equity is projected to be high at 24.4% in three years, further underscoring its growth potential.

TSE:2379 Earnings and Revenue Growth as at Jul 2024
TSE:2379 Earnings and Revenue Growth as at Jul 2024

PeptiDream

Simply Wall St Growth Rating: ★★★★★☆

Overview: PeptiDream Inc. is a biopharmaceutical company focused on the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics, with a market cap of ¥361.22 billion.

Operations: PeptiDream Inc. generates revenue from the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.